Obesity

Christopher Henry Grant, Samira Bell

Read time: 19m 2s

Nir Uriel

Watch time: 34m 39s (5 videos)
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s
Obesity in Focus: Implications for Heart Failure, Kidney Disease, and Pharmacology

Chim C Lang, Bianca Rocca, Samira Bell, et al

Watch time: 14m 14s
ESC 25: The SEMA-VR CardioLink-15 Trial

Subodh Verma

Watch time: 4m 27s
Tirzepatide Benefits in HFpEF Consistent Across Obesity Levels, SUMMIT Analysis Shows

Radcliffe CVRM

New Multi-Ancestry Polygenic Score Improves BMI and Obesity Prediction Across the Lifespan

Radcliffe CVRM

Managing Obesity in HF: 2025 ACC Scientific Statement

Michelle Kittleson

Watch time: 8m 5s
ADA 25: MariTide Treatment for Obesity in Patients with or without T2D

Harold Bays

Watch time: 6m 23s

Sue Pedersen

Watch time: 42m 3s (5 videos)

Chim C Lang

Watch time: 3m 10s
ERA 25: Treating Obesity in 2025 and Beyond

Ruben Nogueiras

Watch time: 4m 16s

Christopher Henry Grant, Samira Bell

Read time: 19m 2s
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s

Nir Uriel

Watch time: 34m 39s (5 videos)

Carmen Lara-Romero, Manuel Romero-Gómez

Read time: 20m 32s

Fausto J Pinto, John Spertus, , et al

Gurushankar Govindarajan, James R Sowers, Craig S Stump

ACC.24: The STEP HFpEF DM Trial

Mikhail Kosiborod

Watch time: 6m 41s

Deesha Patel, Makrina D Savvidou

Read time: 22m 59s

Alberto Lorenzatti, Peter P Toth

Andrew JS Coats, Stefan Anker

EASD 22: SURMOUNT-MMO: Tirepatide in Obese Type II Diabetes Patients

Steven E Nissen

Watch time: 7m 48s

Sheila Gato, Vanessa García-Fernández, Antonio Gil-Gómez, et al

Read time: 20m 25s

About

The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
 

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

Fausto J Pinto, John Spertus, , et al

Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
EP 87: Gut Microbiome and Heart Health: The 3 Compounds You Need to Know About with Dr Vuyisich

Ankur Kalra, Momchilo Vuyisich,

Listen time: 45m 50s

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day Two

Stefan Anker, Javed Butler, Antonio Ceriello, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day One

Stefan Anker, Javed Butler, Antonio Ceriello, et al

Media

Nir Uriel

Watch time: 34m 39s (5 videos)
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s
ESC 25: The SEMA-VR CardioLink-15 Trial

Subodh Verma

Watch time: 4m 27s

Yassir Javaid, ,

Watch time: 1h 7m 32s (4 videos)
Obesity in Focus: Implications for Heart Failure, Kidney Disease, and Pharmacology

Chim C Lang, Bianca Rocca, Samira Bell, et al

Watch time: 14m 14s

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Advancements in Obesity Management (AOM) 2025

Harold Bays, Naveed Sattar, Liesbeth van Rossum, et al

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
AOM 2024

Harold Bays, Naveed Sattar, Mikhail Kosiborod, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2024 - Day 2

Antonio Ceriello, Ileana L Piña, Gianluigi Savarese, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2024 - Day 1

Antonio Ceriello, Ileana L Piña, Gianluigi Savarese, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day Two

Stefan Anker, Javed Butler, Antonio Ceriello, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day One

Stefan Anker, Javed Butler, Antonio Ceriello, et al

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Nocturnal Hypertension

Roland Asmar, , , et al

Watch time: 1h 9m 26s

Articles

Obesity and CKD: The Dual Epidemic in Cardiovascular Health

Christopher Henry Grant

,

Samira Bell

,

Published:

17 October 2025

Citation:

European Cardiology Review 2025;20:e28.

DOI:

https://doi.org/10.15420/ecr.2025.33
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 114
  • Downloads: Downloads 11
  • Read time: 19m 2s

Maternal Cardiac Function in Pregnancies With Metabolic Disorders

Deesha Patel

,

Makrina D Savvidou

,

Published:

19 June 2024

Citation:

European Cardiology Review 2024;19:e08.

DOI:

https://doi.org/10.15420/ecr.2023.28
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 428
  • Downloads: Downloads 24
  • Read time: 22m 59s

Treatment Options and Continuity of Care in MAFLD

Carmen Lara-Romero

,

Manuel Romero-Gómez

,

Published:

19 June 2024

Citation:

European Cardiology Review 2024;19:e06.

DOI:

https://doi.org/10.15420/ecr.2023.34
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1619
  • Downloads: Downloads 61
  • Citations: 11
  • Read time: 20m 32s

Link Between NAFLD/NASH and Cardiometabolic Syndrome

Sheila Gato

,

Vanessa García-Fernández

,

Antonio Gil-Gómez

,

Ángela Rojas

,

Rocío Montero-Vallejo

,

Rocío Muñoz-Hernández

,

Manuel Romero-Gómez

,

Published:

09 May 2024

Citation:

European Cardiology Review 2024;19:e03.

DOI:

https://doi.org/10.15420/ecr.2023.26
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 540
  • Downloads: Downloads 62
  • Citations: 4
  • Read time: 20m 25s